XML 52 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2022   82,653,781      
Beginning balances at Dec. 31, 2022 $ (132,711) $ 9 $ 513,614 $ 6 $ (646,340)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 5,667   5,667    
Exercise of stock options (in shares)   200,000      
Exercise of stock options 268   268    
Release of restricted stock units (in shares)   1,513,333      
Cancellation of shares used to settle payroll tax withholding (in shares)   (290,071)      
Cancellation of shares used to settle payroll tax withholding (451)   (451)    
Issuance of common stock (in shares)   43,232,917      
Issuance of common stock 100,913 $ 5 100,908    
Foreign currency translation adjustment 3     3  
Net loss (203,230)       (203,230)
Ending balances (in shares) at Jun. 30, 2023   127,309,960      
Ending balances at Jun. 30, 2023 (229,541) $ 14 620,006 9 (849,570)
Beginning balances (in shares) at Mar. 31, 2023   95,222,670      
Beginning balances at Mar. 31, 2023 (175,597) $ 10 542,326 7 (717,940)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 2,304   2,304    
Exercise of stock options (in shares)   200,000      
Exercise of stock options 268   268    
Release of restricted stock units (in shares)   598,127      
Cancellation of shares used to settle payroll tax withholding (in shares)   (43,354)      
Cancellation of shares used to settle payroll tax withholding (106)   (106)    
Issuance of common stock (in shares)   31,332,517      
Issuance of common stock 75,218 $ 4 75,214    
Foreign currency translation adjustment 2     2  
Net loss (131,630)       (131,630)
Ending balances (in shares) at Jun. 30, 2023   127,309,960      
Ending balances at Jun. 30, 2023 $ (229,541) $ 14 620,006 9 (849,570)
Beginning balances (in shares) at Dec. 31, 2023 199,133,827 199,133,827      
Beginning balances at Dec. 31, 2023 $ (110,800) $ 21 765,018 7 (875,846)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 4,798   4,798    
Release of restricted stock units (in shares)   1,028,191      
Cancellation of shares used to settle payroll tax withholding (in shares)   (298,326)      
Cancellation of shares used to settle payroll tax withholding (351)   (351)    
Issuance of common stock (in shares)   16,627,523      
Issuance of common stock 14,089 $ 2 14,087    
Series A-1 Preferred Stock accretion to redemption value (23,671)   (23,671)    
Foreign currency translation adjustment (4)     (4)  
Net loss $ (74,880)       (74,880)
Ending balances (in shares) at Jun. 30, 2024 216,491,215 216,491,215      
Ending balances at Jun. 30, 2024 $ (190,819) $ 23 759,881 3 (950,726)
Beginning balances (in shares) at Mar. 31, 2024   206,779,447      
Beginning balances at Mar. 31, 2024 (147,673) $ 22 774,857 2 (922,554)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 1,857   1,857    
Release of restricted stock units (in shares)   370,586      
Cancellation of shares used to settle payroll tax withholding (in shares)   (46,359)      
Cancellation of shares used to settle payroll tax withholding (43)   (43)    
Issuance of common stock (in shares)   9,387,541      
Issuance of common stock 6,882 $ 1 6,881    
Series A-1 Preferred Stock accretion to redemption value (23,671)   (23,671)    
Foreign currency translation adjustment 1     1  
Net loss $ (28,172)       (28,172)
Ending balances (in shares) at Jun. 30, 2024 216,491,215 216,491,215      
Ending balances at Jun. 30, 2024 $ (190,819) $ 23 $ 759,881 $ 3 $ (950,726)